World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
17557
World Ranking
2741
National Ranking
1307

Overview

Friederike Feldmann is affiliated with the National Institutes of Health in the United States. Their research primarily centers on Medicine, with a particular focus on Infectious Diseases, Epidemiology, Modeling and Simulation, Public Health, Environmental and Occupational Health, and Animal Science and Zoology.

The scientist has contributed significantly to research topics including SARS-CoV-2 and COVID-19, Viral Infections and Outbreaks, COVID-19 Clinical Research Studies, Viral Infections and Vectors, SARS-CoV-2 detection and testing, Virology and Viral Diseases, and Respiratory viral infections.

Frequent venues for their research publications include bioRxiv (Cold Spring Harbor Laboratory), where 25 papers have appeared, The Journal of Infectious Diseases with 5 publications, and Nature, Emerging Microbes & Infections, and Science Advances, each hosting 4 of their papers.

Frequent co-authors collaborating with Friederike Feldmann are Heinz Feldmann, Atsushi Okumura, Patrick W. Hanley, Jamie Lovaglio, and Kimberly Meade-White.

Key papers illustrating their research work are:

  • ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques, 2020, Nature
  • Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection, 2020, Proceedings of the National Academy of Sciences
  • Respiratory disease in rhesus macaques inoculated with SARS-CoV-2, 2020, Nature
  • Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2, 2020, Nature
  • ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

    Darwyn Kobasa;Steven M. Jones;Steven M. Jones;Kyoko Shinya;John C. Kash

  • ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.

    Neeltje van Doremalen;Teresa Lambe;Alexandra Spencer;Sandra Belij-Rammerstorfer

  • Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.

    Emmie de Wit;Friederike Feldmann;Jacqueline Cronin;Robert Jordan

  • Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.

    Brandi N. Williamson;Friederike Feldmann;Benjamin Schwarz;Kimberly Meade-White

  • Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.

    Vincent J. Munster;Friederike Feldmann;Brandi N. Williamson;Neeltje van Doremalen

  • Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques

    Darryl Falzarano;Emmie de Wit;Angela L Rasmussen;Friederike Feldmann

  • Effective post-exposure treatment of Ebola infection.

    Heinz Feldmann;Steven M Jones;Steven M Jones;Kathleen M Daddario-DiCaprio;Kathleen M Daddario-DiCaprio;Joan B Geisbert

  • Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

    Emmie de Wit;Angela L. Rasmussen;Darryl Falzarano;Trenton Bushmaker

  • Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance

    Angela L. Rasmussen;Atsushi Okumura;Atsushi Okumura;Martin T Ferris;Richard Green

  • VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain

    Andrea Marzi;Shelly J. Robertson;Elaine Haddock;Friederike Feldmann

  • Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates

    Andrea Marzi;Flora Engelmann;Friederike Feldmann;Kristen Haberthur

  • ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques.

    Neeltje van Doremalen;Teresa Lambe;Alexandra Spencer;Sandra Belij-Rammerstorfer

  • Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

    Michael K. Lo;Friederike Feldmann;Joy M. Gary;Robert Jordan

  • A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

    Karuppiah Muthumani;Darryl Falzarano;Emma L. Reuschel;Colleen Tingey

  • Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool

    Thomas Hoenen;Allison Groseth;Kyle Rosenke;Robert J. Fischer

  • Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.

    Kyle Rosenke;Kimberly Meade-White;Michael Letko;Chad Clancy

  • Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Joan B. Geisbert;Joan B. Geisbert;Douglas S. Reed

  • Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

    Darryl Falzarano;Emmie de Wit;Friederike Feldmann;Angela L. Rasmussen

  • Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.

    Gary P. Kobinger;Heinz Feldmann;Heinz Feldmann;Yan Zhi;Gregory Schumer

  • Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Kinola J. N. Williams;Joan B. Geisbert

  • Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody

    Thomas W. Geisbert;Chad E. Mire;Joan B. Geisbert;Yee Peng Chan

Frequent Co-Authors

Heinz Feldmann
Heinz Feldmann National Institutes of Health
Andrea Marzi
Andrea Marzi National Institutes of Health
Vincent J. Munster
Vincent J. Munster National Institutes of Health
Emmie de Wit
Emmie de Wit National Institutes of Health
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Hideki Ebihara
Hideki Ebihara Mayo Clinic
Steven M. Jones
Steven M. Jones University of Saskatchewan
Joan B. Geisbert
Joan B. Geisbert The University of Texas Medical Branch at Galveston
Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Gary Kobinger
Gary Kobinger The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which can be pursued through specialized online degree programs. For those interested in nursing pathways, exploring accelerated nursing programs near me can be a great starting point. These programs allow students to quickly transition into nursing careers, benefiting from focused curricula and flexible schedules.

Similarly, if you're seeking a faster route into patient care roles, fastest and easiest lpn programs offer practical nursing credentials with streamlined admissions and training processes. These programs often provide essential skills that complement immunological knowledge in clinical settings.

For advanced practice opportunities, knowing which nurse practitioner program is easiest can help prospective students identify flexible, accessible paths to becoming nurse practitioners. This specialization aligns closely with immunology, especially in managing immune-related disorders.

Lastly, focusing on mental health dimensions of immunology, the best online psychiatric mental health nurse practitioner programs provide critical training for those interested in the intersection of immunology and psychiatric care. Strong clinical placements ensure graduates are well-prepared for impactful careers.

Best Scientists Citing Friederike Feldmann

Trending Scientists

Recently Published Articles